185 related articles for article (PubMed ID: 20565940)
1. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?
Nakayama T; Ling ZQ; Mukaisho K; Hattori T; Sugihara H
BMC Cancer; 2010 Jun; 10():311. PubMed ID: 20565940
[TBL] [Abstract][Full Text] [Related]
2. Genetic lineages of undifferentiated-type gastric carcinomas analysed by unsupervised clustering of genomic DNA microarray data.
Sonoda A; Mukaisho K; Nakayama T; Diem VT; Hattori T; Andoh A; Fujiyama Y; Sugihara H
BMC Med Genomics; 2013 Jul; 6():25. PubMed ID: 23866769
[TBL] [Abstract][Full Text] [Related]
3. Progression risk assessments of individual non-invasive gastric neoplasms by genomic copy-number profile and mucin phenotype.
Vo DT; Nakayama T; Yamamoto H; Mukaisho K; Hattori T; Sugihara H
BMC Med Genomics; 2015 Feb; 8():6. PubMed ID: 25881098
[TBL] [Abstract][Full Text] [Related]
4. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours.
Peng DF; Sugihara H; Mukaisho K; Tsubosa Y; Hattori T
J Pathol; 2003 Nov; 201(3):439-50. PubMed ID: 14595756
[TBL] [Abstract][Full Text] [Related]
5. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
6. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
[TBL] [Abstract][Full Text] [Related]
7. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.
Rokutan H; Abe H; Nakamura H; Ushiku T; Arakawa E; Hosoda F; Yachida S; Tsuji Y; Fujishiro M; Koike K; Totoki Y; Fukayama M; Shibata T
J Pathol; 2019 Apr; 247(4):494-504. PubMed ID: 30474112
[TBL] [Abstract][Full Text] [Related]
8. Rapidly and Slowly Growing Lineages in Chromosomal Instability-Type Gland-Forming Gastric Carcinomas as Revealed by Multisampling Analysis of DNA Copy-Number Profile.
Duong TT; Vo DT; Nakayama T; Mukaisho KI; Bamba M; Nguyen TS; Sugihara H
Pathobiology; 2019; 86(2-3):118-127. PubMed ID: 30625481
[TBL] [Abstract][Full Text] [Related]
9. How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: analyses of intratumoral heterogeneity in deletion and mutation of TP53.
Yoshimura A; Sugihara H; Ling ZQ; Peng DF; Mukaisho K; Fujiyama Y; Hattori T
Pathobiology; 2006; 73(1):40-9. PubMed ID: 16785766
[TBL] [Abstract][Full Text] [Related]
10. Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization.
Peng DF; Sugihara H; Mukaisho K; Ling ZQ; Hattori T
J Pathol; 2004 Aug; 203(4):884-95. PubMed ID: 15258990
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
[TBL] [Abstract][Full Text] [Related]
12. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer.
Wu MS; Chang MC; Huang SP; Tseng CC; Sheu JC; Lin YW; Shun CT; Lin MT; Lin JT
Genes Chromosomes Cancer; 2001 Jan; 30(1):80-6. PubMed ID: 11107179
[TBL] [Abstract][Full Text] [Related]
13. Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.
Kohno Y; Yamamoto H; Hirahashi M; Kumagae Y; Nakamura M; Oki E; Oda Y
Hum Pathol; 2016 Jun; 52():145-52. PubMed ID: 26980051
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of the expression of the c-myc oncoprotein in human stomach cancers.
Spandidos DA; Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK
Digestion; 1991; 50(3-4):127-34. PubMed ID: 1812039
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.
Kuroda A; Tsukamoto Y; Nguyen LT; Noguchi T; Takeuchi I; Uchida M; Uchida T; Hijiya N; Nakada C; Okimoto T; Kodama M; Murakami K; Matsuura K; Seto M; Ito H; Fujioka T; Moriyama M
PLoS One; 2011; 6(7):e22313. PubMed ID: 21811585
[TBL] [Abstract][Full Text] [Related]
16. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
Gomyo Y; Osaki M; Kaibara N; Ito H
Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
[TBL] [Abstract][Full Text] [Related]
17. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence In situ hybridization studies.
Koo SH; Kwon KC; Shin SY; Jeon YM; Park JW; Kim SH; Noh SM
Cancer Genet Cytogenet; 2000 Mar; 117(2):97-103. PubMed ID: 10704677
[TBL] [Abstract][Full Text] [Related]
19. MYC, TP53, and chromosome 17 copy-number alterations in multiple gastric cancer cell lines and in their parental primary tumors.
Leal MF; Calcagno DQ; Borges da Costa Jde F; Silva TC; Khayat AS; Chen ES; Assumpção PP; de Arruda Cardoso Smith M; Burbano RR
J Biomed Biotechnol; 2011; 2011():631268. PubMed ID: 21528007
[TBL] [Abstract][Full Text] [Related]
20. hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions.
Silva TC; Leal MF; Calcagno DQ; de Souza CR; Khayat AS; dos Santos NP; Montenegro RC; Rabenhorst SH; Nascimento MQ; Assumpção PP; de Arruda Cardoso Smith M; Burbano RR
BMC Gastroenterol; 2012 Jul; 12():85. PubMed ID: 22768805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
